Analyst Consensus ?
ConsensusBuy28 ratings
Bullish1657.1%
Neutral1242.9%
Bearish00.0%
Leidos Holdings, Inc. · LDOS · FY2025 Q1 · Calendar Q2 2025
Leidos Reaffirms FY2025 Outlook as Cyber and Federal Demand Build
The supplied analysis supports a constructive but conditional view: management sees resilient federal demand and multiple NorthStar 2030 growth avenues, while execution, federal-budget timing, contract reviews, and acquisition integration remain key tests.
Reported Before market openNYSETechnology
$15.56B market cap
80quality score
Earnings scorecard
Reported versus consensus
Reported EPS
—
Consensus $2.47
EPS surprise
—
Reported versus consensus
Reported revenue
—
Consensus $4.10B
Revenue surprise
—
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
+4.6%
Event window
SPY move
-0.8%
Same window
Abnormal move
+5.4%
Stock minus SPY
Volume
1.9×
Versus trailing sessions
Subsequent drift
-6.7%
Up to 20 sessions
LDOSSPY benchmark
Ask FN2 about LDOS FY2025 Q1
Transcript, numbers and history already loaded
What drove LDOS's +4.6% move after FY2025 Q1 earnings?What changed in LDOS's guidance and outlook in FY2025 Q1?Give me the bull and bear case for LDOS after FY2025 Q1 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Relative to the prior-quarter analysis, Leidos maintained its full-year outlook while adding a pending full-spectrum cyber acquisition, emphasizing a $226 billion opportunity pipeline, and continuing the NorthStar 2030 execution focus.
Guidance delta
Management reaffirmed full-year FY2025 guidance; the supplied analysis does not report a numerical change.
Key takeaways
- Management described Q1 as strong, with organic growth and margin expansion.
- The NorthStar 2030 strategy remains the framework for growth across cyber, modernization, defense, energy, and managed health services.
- The company highlighted a $226 billion opportunity pipeline and federal contract momentum.
- Capital deployment included a $500 million accelerated share-repurchase program and a pending full-spectrum cyber acquisition.
- The supplied scorecard does not include actual EPS or revenue, so no beat or miss is asserted.
Management priorities
- Execute the NorthStar 2030 growth pillars.
- Scale managed health services and deepen the VA partnership.
- Pursue FAA air-traffic-control modernization and defense modernization opportunities.
- Integrate the pending cyber acquisition and pursue additional bolt-on acquisitions.
Follow LDOS with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$124.11Current
$105Low
$164.04Average
$230High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 16, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| JP Morgan | Neutral | Overweight | Downgrade | Oct 8, 2026 |
| Citigroup | Buy | Buy | Maintain | Oct 7, 2026 |
| TD Cowen | Hold | Hold | Maintain | Oct 6, 2026 |
| Jefferies | Hold | Hold | Maintain | Oct 6, 2026 |
| B of A Securities | Neutral | Neutral | Maintain | Sep 18, 2026 |
| Goldman Sachs | Neutral | Neutral | Maintain | Aug 12, 2026 |
| UBS | Neutral | Neutral | Maintain | Aug 5, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Aug 5, 2026 |
| BNP Paribas | Outperform | Outperform | Maintain | Aug 5, 2026 |
| Truist Securities | Buy | Buy | Maintain | Jul 10, 2026 |
| Stifel | Hold | Hold | Maintain | May 6, 2026 |
| Baird | Neutral | Neutral | Maintain | Feb 18, 2026 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Oct 31, 2025 |
| Argus Research | Buy | Buy | Maintain | Sep 24, 2025 |
| Wells Fargo | Overweight | Overweight | Maintain | May 8, 2025 |
| William Blair | Market Perform | Outperform | Downgrade | Feb 21, 2025 |
| Barclays | Overweight | Overweight | Maintain | Nov 4, 2024 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Feb 15, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Feb 24, 2021 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Apr 14, 2020 |
| Stifel Nicolaus | Buy | Hold | Upgrade | Mar 2, 2020 |
| Citi | Neutral | Buy | Downgrade | Jul 9, 2019 |
| Argus | Buy | Buy | Maintain | Oct 29, 2018 |
| Vertical Research | Buy | Buy | Maintain | Mar 17, 2017 |
| Oppenheimer | Outperform | Outperform | Maintain | Dec 6, 2016 |
| Deutsche Bank | Hold | Hold | Maintain | Feb 23, 2016 |
| Drexel Hamilton | Buy | Hold | Upgrade | Nov 2, 2015 |
| BB&T Capital | Buy | Hold | Upgrade | Oct 29, 2015 |
Named analyst price targets
Upside is calculated against the persisted current price $124.1. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Jefferies | Sheila Kahyaoglu | $130 | $117.81 | +4.8% | Oct 6, 2026 |
| Cowen & Co. | Analyst unavailable | $135 | $133.05 | +8.8% | Sep 8, 2026 |
| Wells Fargo | David Strauss | $165 | $143.83 | +33.0% | Aug 17, 2026 |
| Goldman Sachs | Noah Poponak | $132 | $140.89 | +6.4% | Aug 12, 2026 |
| Jefferies | Analyst unavailable | $145 | $137.57 | +16.8% | Aug 9, 2026 |
| Robert W. Baird | Analyst unavailable | $150 | $130.6 | +20.9% | Aug 5, 2026 |
| RBC Capital | Ken Herbert | $170 | $130.6 | +37.0% | Aug 5, 2026 |
| Goldman Sachs | Analyst unavailable | $152 | $106.58 | +22.5% | Jul 14, 2026 |
| Truist Financial | Tobey Sommer | $160 | $106.24 | +28.9% | Jul 10, 2026 |
| Jefferies | Analyst unavailable | $110 | $104.81 | -11.4% | Jul 1, 2026 |
| Wells Fargo | Analyst unavailable | $125 | $113.58 | +0.7% | Jun 17, 2026 |
| Jefferies | Sheila Kahyaoglu | $140 | $126.82 | +12.8% | Jun 3, 2026 |
| BNP Paribas | Analyst unavailable | $165 | $131.78 | +33.0% | May 27, 2026 |
| Jefferies | Analyst unavailable | $185 | $160.64 | +49.1% | Apr 8, 2026 |
| Jefferies | Sheila Kahyaoglu | $215 | $173.5 | +73.2% | Feb 23, 2026 |
| RBC Capital | Ken Herbert | $215 | $164.41 | +73.2% | Feb 18, 2026 |
| Robert W. Baird | Analyst unavailable | $195 | $166.2 | +57.1% | Feb 18, 2026 |
| Stifel Nicolaus | Analyst unavailable | $205 | $161.53 | +65.2% | Feb 18, 2026 |
| UBS | Analyst unavailable | $204 | $190.13 | +64.4% | Jan 15, 2026 |
| Stifel Nicolaus | Jonathan Siegmann | $220 | $196.61 | +77.3% | Jan 7, 2026 |
| RBC Capital | Analyst unavailable | $230 | $195.59 | +85.3% | Nov 5, 2025 |
| UBS | Gavin Parsons | $216 | $199.22 | +74.0% | Nov 5, 2025 |
| Truist Financial | Analyst unavailable | $220 | $201.57 | +77.3% | Nov 4, 2025 |
| Cantor Fitzgerald | Analyst unavailable | $225 | $192.09 | +81.3% | Oct 31, 2025 |
| Truist Financial | Tobey Sommer | $195 | $185.61 | +57.1% | Sep 30, 2025 |
| RBC Capital | Ken Herbert | $210 | $177.71 | +69.2% | Sep 3, 2025 |
| Stifel Nicolaus | Analyst unavailable | $178 | $150.67 | +43.4% | Jun 23, 2025 |
| UBS | Gavin Parsons | $168 | $154.75 | +35.4% | May 7, 2025 |
| UBS | Gavin Parsons | $182 | $165.4 | +46.7% | Dec 2, 2024 |
| Goldman Sachs | Noah Poponak | $228 | $185.86 | +83.7% | Oct 29, 2024 |
| Truist Financial | Tobey Sommer | $205 | $185.83 | +65.2% | Oct 29, 2024 |
| Citigroup | Jason Gursky | $194 | $167.67 | +56.3% | Oct 10, 2024 |
| RBC Capital | Ken Herbert | $145 | $144.28 | +16.8% | Jul 31, 2024 |
| Stifel Nicolaus | Bert Subin | $170 | $145.98 | +37.0% | Jul 30, 2024 |
| Stifel Nicolaus | Bert Subin | $165 | $146.57 | +33.0% | Jun 24, 2024 |
| RBC Capital | Ken Herbert | $140 | $144.58 | +12.8% | Jun 13, 2024 |
| Barclays | David Strauss | $160 | $141.67 | +28.9% | May 6, 2024 |
| Robert W. Baird | Peter Arment | $180 | $140.22 | +45.0% | May 1, 2024 |
| Barclays | David Strauss | $130 | $110.17 | +4.8% | Jan 8, 2024 |
| Morgan Stanley | Analyst unavailable | $111 | $104.71 | -10.6% | Jan 3, 2023 |
| Morgan Stanley | Analyst unavailable | $112 | $107.32 | -9.8% | Dec 14, 2022 |
| Citigroup | Analyst unavailable | $130 | $109.57 | +4.8% | Dec 8, 2022 |
| RBC Capital | Ken Herbert | $112 | $110.35 | -9.8% | Dec 2, 2022 |
| RBC Capital | Ken Herbert | $106 | $96.32 | -14.6% | Aug 30, 2022 |
| Morgan Stanley | Analyst unavailable | $110 | $99.57 | -11.4% | Aug 3, 2022 |
| Wells Fargo | Analyst unavailable | $105 | $100.48 | -15.4% | Aug 3, 2022 |
| Wells Fargo | Analyst unavailable | $109 | $103.43 | -12.2% | May 4, 2022 |
| Cowen & Co. | Cai von Rumohr | $105 | $88.72 | -15.4% | Feb 16, 2022 |
| Barclays | Colin Canfield | $110 | $89.07 | -11.4% | Feb 6, 2022 |
| Capital One Financial | Jonathan Raviv | $120 | $101.27 | -3.3% | May 20, 2021 |
Track every rating change on LDOS the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationLeidos Holdings, Inc., along with its various subsidiaries, delivers a broad spectrum of services and innovative solutions across key markets: defense, intelligence, civil government, and health. The company operates both domestically within the United States and on an international scale. Its operations are organized into three principal divisions: Defense Solutions, Civil, and Health. The Defense Solutions segment is dedicated to providing national security systems and specialized support spanning air, land, sea, space, and cyberspace domains. Its extensive client base includes the U.S. Intelligence Community, the Department of Defense, NASA, various military branches, allied foreign governments, and other federal and commercial entities within the national security sector.…
Historical context
All LDOS earningsTechnology peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| WIT Wipro Limited | FY2027 Q2 · Calendar Q4 2026 | -25.0% | +3.9% | Wipro: AI pipeline expands as Q3 guidance stays narrow |
| TSM Taiwan Semiconductor Manufacturing Company Limited | FY2026 Q3 · Calendar Q4 2026 | +3.4% | -1.8% | TSMC beats Q3 guidance as AI demand drives fab expansion |
| ERIC Telefonaktiebolaget LM Ericsson (publ) | FY2026 Q3 · Calendar Q4 2026 | +28.6% | +11.8% | Ericsson Q3: 7% organic growth, resilient margins and AI-led demand |
| ASML ASML Holding N.V. | FY2026 Q3 · Calendar Q4 2026 | +20.4% | -3.9% | ASML: Record Q3, strong AI demand and broader capacity plans |
Latest beats and misses
Who reports nextBeat on EPS
- AAFY2026 Q3 · October 15, 2026+20.5% EPS+7.2% move
- JBHTFY2026 Q3 · October 15, 2026+0.6% EPS-2.0% move
- PLDFY2026 Q3 · October 15, 2026+105.9% EPS-2.7% move
- BNYFY2026 Q3 · October 15, 2026+4.4% EPS+3.2% move
- USB-PRFY2026 Q3 · October 15, 2026+1.5% EPS— move
- USB-PSFY2026 Q3 · October 15, 2026+1.5% EPS— move
Get the LDOS recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2025-04-22T00:02:47.536505+00:00
- Polygon adjusted daily market bars · 2026-10-16T12:40:40.147146+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-16T12:40:40.144211+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-16. For educational purposes only; not investment advice.